Seeking Alpha

UBS upgrades Walgreen (WAG) to a Buy rating from Neutral and sets a $48 price target on shares....

UBS upgrades Walgreen (WAG) to a Buy rating from Neutral and sets a $48 price target on shares. The firm notes the drugstore operator could see stronger gross margins and thinks visibility on the impact of the Alliance Boots transaction is clearer. WAG +1.4% premarket to $41.63.
Comments (1)
  • The express scripts deal hurt WAG in the short run, in the long run it got them off their duffs and made them more competitive
    13 Mar 2013, 09:01 AM Reply Like
DJIA (DIA) S&P 500 (SPY)